| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced glycation in diabetes, aging and age-related diseases: conclusions
|
Monnier, Vincent M.
|
|
2016
|
33 |
4 |
p. 691-692
|
artikel
|
| 2 |
Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication
|
Monnier, Vincent M
|
|
2016
|
33 |
4 |
p. 483-486
|
artikel
|
| 3 |
AGE-RAGE interaction in the TGFβ2-mediated epithelial to mesenchymal transition of human lens epithelial cells
|
Raghavan, Cibin T.
|
|
2016
|
33 |
4 |
p. 631-643
|
artikel
|
| 4 |
Antibody-based detection of advanced glycation end-products: promises vs. limitations
|
Nagai, Ryoji
|
|
2016
|
33 |
4 |
p. 545-552
|
artikel
|
| 5 |
Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study
|
Gurecká, Radana
|
|
2016
|
33 |
4 |
p. 599-606
|
artikel
|
| 6 |
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
|
Zhuang, Aowen
|
|
2016
|
33 |
4 |
p. 645-652
|
artikel
|
| 7 |
Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
|
Rabbani, Naila
|
|
2016
|
33 |
4 |
p. 513-525
|
artikel
|
| 8 |
Dicarbonyl stress in clinical obesity
|
Masania, Jinit
|
|
2016
|
33 |
4 |
p. 581-589
|
artikel
|
| 9 |
DNA-aptamers raised against AGEs as a blocker of various aging-related disorders
|
Yamagishi, Sho-ichi
|
|
2016
|
33 |
4 |
p. 683-690
|
artikel
|
| 10 |
Dysfunctional protection against advanced glycation due to thiamine metabolism abnormalities in gestational diabetes
|
Bartáková, Vendula
|
|
2016
|
33 |
4 |
p. 591-598
|
artikel
|
| 11 |
Glycation vs. glycosylation: a tale of two different chemistries and biology in Alzheimer’s disease
|
Taniguchi, Naoyuki
|
|
2016
|
33 |
4 |
p. 487-497
|
artikel
|
| 12 |
Glyoxalase-1 overexpression partially prevents diabetes-induced impaired arteriogenesis in a rat hindlimb ligation model
|
Brouwers, Olaf
|
|
2016
|
33 |
4 |
p. 627-630
|
artikel
|
| 13 |
Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions
|
Neviere, Remi
|
|
2016
|
33 |
4 |
p. 607-617
|
artikel
|
| 14 |
Iridoids are natural glycation inhibitors
|
West, Brett J.
|
|
2016
|
33 |
4 |
p. 671-681
|
artikel
|
| 15 |
Mass spectrometric determination of early and advanced glycation in biology
|
Rabbani, Naila
|
|
2016
|
33 |
4 |
p. 553-568
|
artikel
|
| 16 |
Pathways of the Maillard reaction under physiological conditions
|
Henning, Christian
|
|
2016
|
33 |
4 |
p. 499-512
|
artikel
|
| 17 |
RAGE and glyoxalase in kidney disease
|
Inagi, Reiko
|
|
2016
|
33 |
4 |
p. 619-626
|
artikel
|
| 18 |
Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes
|
Fokkens, Bernardina T.
|
|
2016
|
33 |
4 |
p. 527-535
|
artikel
|
| 19 |
Systemic effects of AGEs in ER stress induction in vivo
|
Adamopoulos, Christos
|
|
2016
|
33 |
4 |
p. 537-544
|
artikel
|
| 20 |
Targeting advanced glycation with pharmaceutical agents: where are we now?
|
Borg, Danielle J.
|
|
2016
|
33 |
4 |
p. 653-670
|
artikel
|
| 21 |
The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes
|
Monnier, Vincent M.
|
|
2016
|
33 |
4 |
p. 569-579
|
artikel
|
Tijdschrift beschrijving